Cite
Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival
MLA
Ryan M. Levy, et al. Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival. Apr. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3b1e4e3d37508f44deb7e77b687bc586&authtype=sso&custid=ns315887.
APA
Ryan M. Levy, Kristi L. Cressman, Weijing Sun, James D. Luketich, Tyler Foxwell, Aatur D. Singhi, Nathan Bahary, Katie S. Nason, Kevin McGrath, Herbert J. Zeh, & Jon M. Davison. (2015). Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival.
Chicago
Ryan M. Levy, Kristi L. Cressman, Weijing Sun, James D. Luketich, Tyler Foxwell, Aatur D. Singhi, Nathan Bahary, et al. 2015. “Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3b1e4e3d37508f44deb7e77b687bc586&authtype=sso&custid=ns315887.